Pulmatrix, Inc.

Biotech Framingham, MA

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Framingham, MA
Street
945 Concord Street
Zip
01701

Offering

Total offering
$1M
Amount sold
$1M
First sale
Mar 26, 2026
Min investment
$1M
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
1

How this filing compares

Ranked #37 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.3× the median.

Other Massachusetts filings this week: ALPINE TORTILLA HOLDCO, INC., Base Camp Fund, Base Camp Fund II, BROOKDALE INTERNATIONAL PARTNERS, L.P., Cahaba Partners Core Fixed Income Fund

Leadership

Michael Higgins — Director

Todd Bazemore — Director

Richard Batycky — Director

Christopher Cabell — Director

Anand Varadan — Director

Peter Ludlum — Executive Officer

Filing details

Pulmatrix, Inc. filed a Form D with the SEC on April 15, 2026.

Other newest Biotech companies

Other newest companies in Massachusetts